Antioxidant Signature in Adult Patients With Phenylketonuria
NCT02212288 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2017-01-16
Summary
To date, oxidative stress in PKU has been evaluated only with fragmented approaches.The aim of the present study is to investigate oxidative stress in PKU with more comprehensive methods.The relationship between oxidative stress and metabolic disturbances (hyperPhenylalaninemia) will also be studied.
Conditions
- PKU
- Hyperphenylalaninemia
Interventions
- OTHER
-
Blood sample
Blood samples are for metabolic and genetic and biological investigation
- OTHER
-
Urine sample
Urine sample for biological investigation
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
collaborator OTHER_GOV -
University Hospital, Tours
lead OTHER
Principal Investigators
-
François MAILLOT, MD-PhD · University Hospital of TOURS, France
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2015-01-31
- Completion
- 2015-01-31
Countries
- France
Study Locations
More Related Trials
-
Evaluation of PKU Explore
NCT03168399 ·Status: COMPLETED ·Phase: NA
-
Simple Breath Test to Examine Phenylalanine Metabolism
NCT02009904 ·Status: COMPLETED
-
A Prospective Clinical Study of Phenylketonuria (PKU)
NCT04452513 ·Status: COMPLETED
-
SNAP: Study Nutrients in Adult PKU
NCT03858101 ·Status: COMPLETED
-
Phenylketonuria, Oxidative Stress, and BH4
NCT01395394 ·Status: TERMINATED ·Phase: PHASE2
-
Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS
NCT02014883 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of CDX-6114 in Patients With Phenylketonuria (PKU)
NCT04085666 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of BH4 Responsiveness in Our PKU Patients
NCT07255599 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
NCT07220265 ·Status: RECRUITING ·Phase: NA
-
PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry
NCT00778206 ·Status: COMPLETED
-
A Long-Term Study of JNT-517 in Participants With Phenylketonuria
NCT06628128 ·Status: RECRUITING ·Phase: PHASE3
-
Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects With Phenylketonuria (PKU)
NCT01212744 ·Status: COMPLETED ·Phase: PHASE2
-
A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults
NCT03505125 ·Status: COMPLETED
-
Evaluation of PKU Sphere Liquid
NCT05096988 ·Status: COMPLETED ·Phase: NA
-
Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of CDX 6114 in PKU Patients
NCT04256655 ·Status: WITHDRAWN ·Phase: PHASE1
-
Natural History Clinical Study in Adult PKU
NCT04768348 ·Status: TERMINATED
-
The Effects of Sapropterin Dihydrochloride Supplementation on in Vivo Redox Status in Patients With Classical PKU
NCT01650909 ·Status: WITHDRAWN
-
Safety and Efficacy Study of NGGT002 in cPKU Adult Subjects
NCT06687733 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Long-Term Safety Study of PTC923 in Participants With Phenylketonuria
NCT05166161 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase
NCT03856203 ·Status: COMPLETED
-
Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study
NCT01924026 ·Status: COMPLETED
-
Pyruvate Kinase Deficiency Natural History Study
NCT02053480 ·Status: COMPLETED
-
Nutritional Status in Phenylketonuria
NCT03820804 ·Status: COMPLETED
-
Safety and Tolerability Study of rAvPAL-PEG to Treat Phenylketonuria
NCT00634660 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)
NCT00924703 ·Status: COMPLETED ·Phase: PHASE2